1-12 of 12
Praneeth Baratam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205)

Amer M. Zeidan, Hongyan Tong, Zhijian Xiao, Praneeth Baratam, Ramzi Abboud, Christopher B. Benton, Joshua F Zeidner, Uma Borate, Wanxing Chai-Ho, Yonglin Lu, Jie Yang, Mingxiu Hu, Baiyong Li, Michelle Xia, David Sallman
Journal: Blood
Blood (2024) 144 (Supplement 1): 6705.
https://doi.org/10.1182/blood-2024-200541
Published: 2024
Journal Articles

Ivosidenib in Patients with Mutant Isocitrate Dehydrogenase 1 (m IDH1 ) Relapsed/Refractory Myelodysplastic Syndromes: Update of the Phase 1 Substudy per the International Working Group 2023 Response Criteria

Yazan F Madanat, Amir T. Fathi, Guillermo Garcia-Manero, Gail J. Roboz, Justin M. Watts, Gabrielle T. Prince, Praneeth Baratam, Stephane De Botton, Anthony S. Stein, James M. Foran, Martha L. Arellano, David Sallman, Yuanye (Vickie) Zhang, Stephanie M. Kapsalis, Prapti A. Patel, Courtney D. DiNardo
Journal: Blood
Blood (2024) 144 (Supplement 1): 1841.
https://doi.org/10.1182/blood-2024-204862
Published: 2024
Journal Articles

PF-08046040 (SEA-CD70), a Nonfucosylated CD70-Directed Antibody, in Combination with Azacitidine for Patients with Myelodysplastic Syndromes (MDS): A Phase 1 Dose-Finding and Dose Expansion Study

Nicole R. Grieselhuber, Praneeth Baratam, Anjali S. Advani, Abdulraheem Yacoub, Don A. Stevens, Ahmed Aribi, Ben K. Tomlinson, Jay Yang, Pankit Vachhani, Joseph G Jurcic, Caspian H. Oliai, Jessica Liegel, Edward Pearson, Anna Van Rhenen, Marcello Rotta, Kapil Rathi, Juan Pinelli, Tara Chen, Amir T. Fathi
Journal: Blood
Blood (2024) 144 (Supplement 1): 1840.
https://doi.org/10.1182/blood-2024-199634
Published: 2024
Journal Articles

Results from a Phase 1 Open-Label Dose Escalation and Expansion Trial of Oral Azacitidine + Cedazuridine (ASTX030) in Patients with Myelodysplastic Syndromes (MDS) and MDS/Myeloproliferative Neoplasms (MPN)

Guillermo Garcia-Manero, James McCloskey, Bart L. Scott, Elizabeth A. Griffiths, Bonnie Kiner-Strachan, Andrew M. Brunner, Amer M. Zeidan, Elie Traer, Yazan F. Madanat, Janelle Meyer, Harry Erba, Praneeth Baratam, Uma Borate, Yuri Sano, Aram Oganesian, Lixia Zhu, Harold N. Keer, Michael R. Savona
Journal: Blood
Blood (2024) 144 (Supplement 1): 662.
https://doi.org/10.1182/blood-2024-203569
Published: 2024
Journal Articles

Improved Hematologic Recovery with Ivosidenib in Patients with mIDH1 Relapsed or Refractory MDS: Results from a Phase 1 Substudy

Gabrielle T. Prince, Praneeth Baratam, Guillermo Garcia-Manero, Anne Angiolillo, Tarun Bhagnani, Assaf Vestin, Amir T. Fathi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3226.
https://doi.org/10.1182/blood-2024-209071
Published: 2024
Journal Articles

Impact of PTPN11 Mutations in De Novo, Secondary and Relapsed/Refractory Acute Myeloid Leukemia

Alexander Coltoff, Deidra Smith, James A Davis, Kelly J Gaffney, Praneeth Baratam, Kimberly Michelle Green
Journal: Blood
Blood (2023) 142 (Supplement 1): 5991.
https://doi.org/10.1182/blood-2023-182407
Published: 2023
Journal Articles

Loss of Heterozygosity of Chromosome 9p and Progression in MPNs

Alexander Coltoff, Kimberly Michelle Green, Praneeth Baratam
Journal: Blood
Blood (2023) 142 (Supplement 1): 6426.
https://doi.org/10.1182/blood-2023-185061
Published: 2023
Journal Articles

Real World Outcomes of CPX-351 Compared to Traditional Chemotherapy with Cytarabine Consolidation for Treatment of Secondary Acute Myeloid Leukemia

Katelynn Granger, Kelly J Gaffney, Deidra Smith, Erin Weeda, Praneeth Baratam, Kimberly Michelle Green, Alexander Coltoff, James A Davis
Journal: Blood
Blood (2023) 142 (Supplement 1): 5922.
https://doi.org/10.1182/blood-2023-174231
Published: 2023
Journal Articles

Lower-Intensity CPX-351 + Venetoclax for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy: Post Hoc Analysis By Disease Risk Subgroups

Tara L. Lin, Praneeth Baratam, Robert K. Stuart, Roland B. Walter, Eric S. Winer, Stefan Faderl, Vijayalakshmi Chandrasekaran, Divya Chakravarthy, Ronald S. Cheung, Vinod A. Pullarkat
Journal: Blood
Blood (2022) 140 (Supplement 1): 3280–3281.
https://doi.org/10.1182/blood-2022-159635
Published: 2022
Journal Articles

Phase 1b Study of Lower-Dose CPX-351 Plus Venetoclax As First-Line Treatment for Patients with AML Who Are Unfit for Intensive Chemotherapy: Preliminary Safety and Efficacy Results

Geoffrey L. Uy, Vinod A. Pullarkat, Praneeth Baratam, Robert K. Stuart, Stefan Faderl, Vijayalakshmi Chandrasekaran, Qi Wang, Divya Chakravarthy, Ronald S. Cheung, Tara L. Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2316.
https://doi.org/10.1182/blood-2021-148455
Published: 2021
Journal Articles

Trends in Mortality, Hospital Cost, and Length of Stay in Lung Cancer Patients with and without Iron Deficiency Anemia: Data from the Healthcare Cost and Utilization Project from 1999-2014

Stuthi Perimbeti, MD MPH, Kathleen Degen, MD, Kevin Ye Hou, MD, Erika Correa, MD MS, Praneeth Baratam, MD, Kristine Ward, MD, David Topolsky, MD, Maneesh Jain, MD, Pamela Ann Crilley, DO, Michael Styler, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5578.
https://doi.org/10.1182/blood.V130.Suppl_1.5578.5578
Published: 2017
Journal Articles

Impact of Iron Deficiency Anemia on Inpatient Mortality, Hospital Cost, and Length of Stay in Patients with Luminal Gastrointestinal Cancers: Data from the Healthcare Cost and Utilization Project from 1999-2014

Praneeth Baratam, MD, Erika Correa, MD MS, Stuthi Perimbeti, MD MPH, Michael Styler, MD, David Topolsky, MD, Pamela Ann Crilley, DO, Maneesh Jain, MD, Kristine Ward, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4669.
https://doi.org/10.1182/blood.V130.Suppl_1.4669.4669
Published: 2017